Purpose: We reviewed the outcomes in men treated with permanent prostate brachytherapy (PPB).
Material And Methods: A total of 1,449 consecutive patients with a mean age of 68 years treated with PPB between 1992 and 2000 and mean pretreatment prostate specific antigen (PSA) 10.1 ng/ml were included in this study.
Int J Radiat Oncol Biol Phys
July 2006
Purpose: To evaluate the correlation of real-time dynamic prostate brachytherapy (RTDPB) dosimetry and traditional postimplant dosimetry for permanent prostate brachytherapy.
Methods And Materials: A total of 164 patients underwent RTDPB for clinically confined prostate cancer. Of these 164 patients, 45 were implanted with 103Pd and 119 with 125I.
Purpose: We reviewed the outcomes in men treated with permanent prostate brachytherapy (PPB).
Material And Methods: A total of 1,449 consecutive patients with a mean age of 68 years treated with PPB between 1992 and 2000 and mean pretreatment prostate specific antigen (PSA) 10.1 ng/ml were included in this study.